P&G to Help Speed COVID-19 Testing

January 26, 2021

Procter & Gamble (P&G), parent company of Procter & Gamble Professional, has entered into a strategic partnership with Rhinostics Inc.

The agreement calls for P&G’s iMFLUX subsidiary to license its novel nasal swab to Rhinostics. The unique features of P&G’s swab allow Rhinostics to apply it to both PCR and antigen-based testing for COVID-19, reducing handling and processing cycle time while increasing lab capacity.

“We are proud to see the P&G-developed nasal swab come to market through Rhinostics’ efforts. When we began this program, our intention was simply to help relieve bottlenecks in COVID-19 swab supply and bring a novel collection device to bear on the problem,” said Mary Wagner, P&G senior vice president and iMFLUX CEO.

About Procter & Gamble Professional
Procter & Gamble Professional is the away-from-home division of Procter & Gamble, serving the food service, building cleaning and maintenance, hospitality, and convenience store industries. For more information, visit